Lymphatic endothelial cell-mediated accumulation of CD177+Treg cells suppresses antitumor immunity in human esophageal squamous cell carcinoma

Lymphatic endothelial cell-mediated accumulation of CD177+Treg cells suppresses antitumor immunity in human esophageal squamous cell carcinoma

Regulatory T (Treg) cells are critical in shaping an immunosuppressive microenvironment to favor tumor progression and resistance to therapies. However, the heterogeneity and function of Treg cells in esophageal squamous cell carcinoma (ESCC) remain underexplored. We identified CD177 as a tumor-infi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Min Ma, Liang Li, Shu-Han Yang, Chuan Huang, Weitao Zhuang, Shujie Huang, Xin Xia, Yong Tang, Zijun Li, Zhi-Bin Zhao, Qingyun Chen, Guibin Qiao, Zhe-Xiong Lian
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2024-12-01
Series:	OncoImmunology
Subjects:	Anti-PD-1 immunotherapy esophageal squamous cell carcinoma regulatory T cell tumor microenvironment CD177 Lymphatic endothelial cell
Online Access:	https://www.tandfonline.com/doi/10.1080/2162402X.2024.2327692
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Axillary adipose tissue–derived lymphatic endothelial cells exhibit distinct transcriptomic signatures reflecting lymphatic invasion status in breast cancer
by: Asumi Iesato, et al.
Published: (2025-06-01)

Mechanisms of Cancer Cell Lymphatic Endothelialization in Tumor Lymphangiogenesis and Metastasis: A Comprehensive Review
by: Wang J, et al.
Published: (2025-08-01)

An acidic microenvironment promotes lymphatic metastasis of melanoma by Thy-1 in endothelial cells and integrin αvβ3 in tumor cells
by: Akiya Ibe, et al.
Published: (2025-04-01)

Dose-Dependent Cellular Phenotypic Change Induced by <sup>177</sup>Lu-Oxodotreotide Treatment in IMR-32 Cells
by: Shuai Xue, et al.
Published: (2025-06-01)

Changes in PD-1 expression on T lymphocyte subsets and related immune indicators before and after definitive chemoradiotherapy for esophageal squamous cell carcinoma
by: Xueling Shi, et al.
Published: (2025-12-01)

Prognostic value of tumor‐infiltrating lymphocytes and PD‐L1 expression in esophageal squamous cell carcinoma
by: Jie Hu, et al.
Published: (2024-09-01)

Closing in on pacemaker cells
by: Pin-Ji Lei, et al.
Published: (2025-07-01)

IL-6 is a prognostic biomarker in patients with advanced esophageal squamous cell carcinoma received with PD-1 inhibitors
by: Ping Huang, et al.
Published: (2025-05-01)

The intratumoral landscape of T cell receptor repertoire in esophageal squamous cell carcinoma
by: Meng Yang, et al.
Published: (2024-11-01)

Preliminary Study on Lutetium-177 and Gold Nanoparticles: Apoptosis and Radiation Enhancement in Hepatic Cancer Cell Line
by: Maria Anthi Kouri, et al.
Published: (2024-10-01)

Application of Esophageal Sponge Cytology in Screening Esophageal Squamous Cell Carcinoma in a High‐Risk Region of China
by: Shu Huang, et al.
Published: (2025-02-01)

Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma
by: Xiaqin Zhang, et al.
Published: (2025-01-01)

Neoadjuvant chemoimmunotherapy for small cell carcinoma of the esophagus: Clinical efficacy and biomarker exploration
by: Junhan Wu, et al.
Published: (2024-12-01)

Unveiling SSR4: a promising biomarker in esophageal squamous cell carcinoma
by: Jiaqi Zhang, et al.
Published: (2025-02-01)

COMPETITION RESPONSE OF PSMA-I&T RADIOLABELED WITH LUTETIUM-177 TO LNCAP, PC-3 AND RWPE-1 CELLS
by: Luiza M Balieiro, et al.
Published: (2025-05-01)

Efficacy and safety of PD-1/PD-L1 inhibitors as first-line treatment for esophageal squamous cell carcinoma: a systematic review and meta-analysis
by: Wei Ren, et al.
Published: (2025-03-01)

Enhancing Th17 cells drainage through meningeal lymphatic vessels alleviate neuroinflammation after subarachnoid hemorrhage
by: Dandan Gao, et al.
Published: (2024-10-01)

Corrigendum: Efficacy and safety of PD-1/PD-L1 inhibitors as first-line treatment for esophageal squamous cell carcinoma: a systematic review and meta-analysis
by: Wei Ren, et al.
Published: (2025-05-01)

Multifactorial analysis of radiochemical purity in high-activity 177Lu-labeled theranostics: impact of precursor source, 177Lu form, and production parameters
by: William Hunt, et al.
Published: (2025-07-01)

Prognostic values of intracellular cell-related genes in esophageal cancer and their regulatory mechanisms
by: Wei Cao, et al.
Published: (2025-01-01)

Cross-talk between cardiac lymphatics and immune cells regulates inflammatory response and cardiac recovery after myocardial infarction
by: Zhihua Yang, et al.
Published: (2025-05-01)

Endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma in patients with cirrhosis and esophageal varices
by: Tomoaki Mochimaru, et al.
Published: (2023-04-01)

Immunotherapy in advanced esophageal squamous cell cancer: earlier or later?
by: Shuang Wei, et al.
Published: (2025-07-01)

Clinical outcomes of esophageal squamous cell carcinoma in patients aged over 80 years
by: Dae Gon Ryu, et al.
Published: (2025-03-01)

Incidence trends of esophageal squamous cell and adenocarcinoma in Finland in 2000–2021
by: Pietari Junkala, et al.
Published: (2025-08-01)

Sugemalimab plus chemotherapy vs. chemotherapy for treatment of Chinese patients with esophageal squamous cell carcinoma: a cost effectiveness analysis to inform decision making
by: Qiuping Chen, et al.
Published: (2025-06-01)

Neoadjuvant chemotherapy with or without PD-1/PD-L1 inhibitors in resectable esophageal squamous cell carcinoma: a meta-analysis based on randomized controlled trials
by: Ye Zhang, et al.
Published: (2025-05-01)

PSD3 as a context-dependent modulator of immune landscape and tumor aggressiveness in esophageal squamous cell carcinoma
by: Shujuan Luo, et al.
Published: (2025-08-01)

CircNF1 modulates the progression and immune evasion of esophageal squamous cell carcinoma through dual regulation of PD-L1
by: Chang Wang, et al.
Published: (2025-03-01)

A phase 2 study of spartalizumab (PDR001) among patients with recurrent or metastatic esophageal squamous cell carcinoma (KCSG HN18-17, K-MASTER project 12)
by: Dong Ki Lee, et al.
Published: (2024-12-01)

Combination therapy with expanded natural killer cells and atezolizumab exerts potent antitumor immunity in small cell lung cancer
by: Manh-Cuong Vo, et al.
Published: (2025-03-01)

Circulating Tumor DNA Dynamic Changes in Esophageal Squamous Cell Carcinoma Receiving Immunochemotherapy
by: Yijia Guo, et al.
Published: (2025-05-01)

Neoadjuvant chemoradiotherapy for thoracic esophageal squamous cell carcinoma: does everyone need it?
by: D. A. Chichevatov, et al.
Published: (2024-05-01)

Characteristics of Esophageal Squamous Cell Carcinomas Based on Circumferential Localization
by: Natsuki Ishida, et al.
Published: (2024-12-01)

Extracellular vesicles derived from creeping fat stem cells promote lymphatic function and restrain inflammation of Crohn's disease
by: Weigang Shu, et al.
Published: (2024-12-01)

Identification of disulfidptosis in esophageal squamous cell carcinoma based on single-cell and bulk RNA-seq data to predict prognosis and treatment response
by: Xiaodan Zhang, et al.
Published: (2025-04-01)

Single-cell RNA sequencing reveals adrb1 as a sympathetic nerve-regulated immune checkpoint driving T cell exhaustion and impacting immunotherapy in esophageal squamous cell carcinoma
by: Qun Li, et al.
Published: (2025-05-01)

Novel miRNA markers and their mechanism of esophageal squamous cell carcinoma (ESCC) based on TCGA
by: Ping Yuan, et al.
Published: (2024-11-01)

Long-term prognosis and DNA damage status after oral mucosal epithelial cell sheet transplantation following esophageal endoscopic submucosal dissection for squamous cell carcinoma: A case series
by: Yasuhiro Maruya, et al.
Published: (2024-06-01)

Research Status and Progress on Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma in Hebei Province
by: Xiaoyang DUAN, et al.
Published: (2025-02-01)